Literature DB >> 22550011

Pulmonary toxicity after initiation of azathioprine for treatment of interstitial pneumonia in a patient with rheumatoid arthritis.

Takaaki Ishida, Takuya Kotani, Tohru Takeuchi, Shigeki Makino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22550011     DOI: 10.3899/jrheum.111415

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement.

Authors:  Andréa Tavares Dantas; Sayonara Maria Calado Gonçalves; Michelly Cristiny Pereira; Rafaela Silva Guimarães Gonçalves; Cláudia Diniz Lopes Marques; Moacyr Jesus Barreto de Melo Rego; Ivan da Rocha Pitta; Angela Luzia Branco Pinto Duarte; Maira Galdino da Rocha Pitta
Journal:  Clin Rheumatol       Date:  2015-07-11       Impact factor: 2.980

Review 2.  Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.

Authors:  Robert W Hallowell; Maureen R Horton
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

3.  Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases?

Authors:  Sahajal Dhooria; Ritesh Agarwal; Dheeraj Gupta
Journal:  Lung India       Date:  2015 Jan-Feb

4.  Hypersensitivity pneumonitis associated with azathioprine therapy in a patient with granulomatosis with polyangiitis.

Authors:  In Hee Lee; Gun Woo Kang; Kyung Chan Kim
Journal:  Rheumatol Int       Date:  2016-05-07       Impact factor: 2.631

Review 5.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.